Aurinia Pharmaceuticals Inc (AUPH)

Apr 14, 2026

How activist investor Kevin Tang finally landed the Bay Area company that got away from him - The Business Journals

Apr 14, 2026

Apr 14, 2026

Trading Systems Reacting to (AUPH) Volatility - Stock Traders Daily

Apr 14, 2026

Apr 14, 2026

Aurinia to Acquire Kezar (NASDAQ: KZR) for $6.955 Cash plus CVR - Stock Titan

Apr 14, 2026

Apr 13, 2026

Ideas Watch: Is Aurinia Pharmaceuticals Inc gaining market sharePortfolio Gains Report & Fast Gaining Stock Reports - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Guidance Update: Does Aurinia Pharmaceuticals Inc stock have upside surprise potentialBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

Aurinia to buy Kezar (KZR) for $6.955/Share plus CVR (7.39M shares) - Stock Titan

Apr 13, 2026

Apr 13, 2026

AUPH Stock Price, Quote & Chart | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill

Apr 13, 2026

Apr 13, 2026

Dow Update: Whats the profit margin of Aurinia Pharmaceuticals Inc2026 Summary & Detailed Earnings Play Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 12, 2026

Proxy StatementNotice of Shareholders Meeting (preliminary) (pre 14a) - ADVFN

Apr 12, 2026

Apr 12, 2026

AUPHAurinia Announces Results of Annual General Meeting - ADVFN

Apr 12, 2026

Apr 11, 2026

RSI Check: Can Aurinia Pharmaceuticals Inc grow without external fundingDip Buying & Short-Term High Return Ideas - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Downgrade Watch: Why is Aurinia Pharmaceuticals Inc stock going up2026 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Kezar Life Sciences shares surge after Aurinia announces acquisition - MSN

Apr 11, 2026

Apr 10, 2026

Stock Analysis: Will Aurinia Pharmaceuticals Inc benefit from government policyEarnings Risk Report & Risk Managed Trade Strategies - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

7MM Systemic Lupus Erythematosus and Lupus Nephritis Drug Market Analysis & Forecast 2024-2034: Future SLE and LN Players Competition, High Unmet Need for Steroid-sparing Treatments - GlobeNewswire Inc.

Apr 10, 2026

Apr 10, 2026

AUPH News | AURINIA PHARMACEUTICALS INC (NASDAQ:AUPH) - ChartMill

Apr 10, 2026

Apr 09, 2026

Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - Sahm

Apr 09, 2026

Apr 08, 2026

AUPH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 08, 2026

Apr 07, 2026

AUPH Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 07, 2026

Apr 06, 2026

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2025 Earnings Call Transcript - MSN

Apr 06, 2026

Apr 06, 2026

Moving Averages: Is Aurinia Pharmaceuticals Inc part of any major index2026 Retail Activity & Safe Entry Momentum Tips - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Aurinia Pharmaceuticals acquiring Kezar Life Sciences - MSN

Apr 06, 2026

Apr 06, 2026

A Look At Aurinia Pharmaceuticals (AUPH) Valuation After Its Recent Leadership Overhaul - Sahm

Apr 06, 2026

Apr 06, 2026

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Apr 06, 2026

Apr 04, 2026

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.96 Per Share Plus Contingent Value Rights in 2026 Merger Deal - Minichart

Apr 04, 2026

Apr 04, 2026

Why Aurinia Pharmaceuticals stock is surging Monday morning - MSN

Apr 04, 2026

Apr 03, 2026

Aurinia Pharmaceuticals to Acquire Kezar, Expanding Autoimmune Pipeline - TipRanks

Apr 03, 2026

Apr 03, 2026

Aurinia to Acquire Kezar via $6.955-Per-Share Cash Tender Plus CVR - TradingView — Track All Markets

Apr 03, 2026

Apr 03, 2026

Aurinia (NASDAQ: AUPH) to acquire Kezar with $6.955 per share cash and CVRs - Stock Titan

Apr 03, 2026

Apr 03, 2026

Aurinia to acquire Kezar (NASDAQ: KZR) for $6.955 cash plus CVR - Stock Titan

Apr 03, 2026

Apr 03, 2026

How Aurinia Pharmaceuticals Inc (AUPH) Affects Rotational Strategy Timing - Stock Traders Daily

Apr 03, 2026

Apr 03, 2026

Aurinia Pharmaceuticals Inc. (AUP.TO) Competitors - Meyka

Apr 03, 2026

Apr 02, 2026

Aurinia Pharmaceuticals (AUPH) COO Ryan Cole becomes SEC Form 3 insider - Stock Titan

Apr 02, 2026

Apr 02, 2026

Aurinia Pharmaceuticals (AUPH) CFO Michael Hearne becomes reporting insider with Form 3 - Stock Titan

Apr 02, 2026

Apr 01, 2026

Major Kezar (KZR) shareholder signs merger support pact and drops bid - Stock Titan

Apr 01, 2026

Apr 01, 2026

JPMorgan Chase & Co. Grows Stock Holdings in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Apr 01, 2026

Mar 31, 2026

Aurinia Pharmaceuticals: $6.955 Per Share Acquisition Of Kezar Life Sciences To Expand Autoimmune Pipeline - Pulse 2.0

Mar 31, 2026

Mar 31, 2026

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Zenopa

Mar 31, 2026

Mar 31, 2026

Aurinia to acquire Kezar Life Sciences - The Pharma Letter

Mar 31, 2026

Mar 30, 2026

EBIT per share of Aurinia Pharmaceuticals Inc. – LSE:0UJF - TradingView

Mar 30, 2026

Mar 30, 2026

KZR Acquisition by Aurinia Pharmaceuticals Valued at $6.955 per Share - GuruFocus

Mar 30, 2026

Mar 30, 2026

Aurinia to Acquire Kezar Life Sciences (KZR) in Strategic Deal - GuruFocus

Mar 30, 2026

Mar 30, 2026

After failed takeover bid, activist investor finds new way to buy out Bay Area company - The Business Journals

Mar 30, 2026

Mar 30, 2026

Aurinia Pharma U.S., Inc. agreed to acquire Kezar Life Sciences, Inc. for $51 million. - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Aurinia to acquire Kezar Life Sciences for $6.955 per share By Investing.com - Investing.com South Africa

Mar 30, 2026

Mar 30, 2026

Aurinia Pharmaceuticals Acquires Kezar Life Sciences - Contract Pharma

Mar 30, 2026

Mar 30, 2026

Aurinia to Buy Kezar Life Sciences in Cash-and-CVR Autoimmune Deal - TipRanks

Mar 30, 2026

Mar 30, 2026

Kezar Life Sciences stock jumps on Aurinia acquisition deal By Investing.com - Investing.com Australia

Mar 30, 2026